Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green Tea Catechins in Men on Active Surveillance for Prostate Cancer
NCT04300855Phase 2Active, not recruiting
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2020
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of green tea extract in prostate cancer (PCa), sponsored by Moffitt Cancer Center. Started Aug 2020; status: active, not recruiting.
02
Drugs
green tea extract
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04300855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300855.